Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering precision nanoparticles for drug delivery
Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 2, pp. 101-124
Open Access | Times Cited: 5155

Showing 1-25 of 5155 citing articles:

Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
Rumiana Tenchov, Robert E. Bird, Allison Curtze, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 16982-17015
Closed Access | Times Cited: 1324
The blood–brain barrier: Structure, regulation and drug delivery
Di Wu, Qi Chen, Xiaojie Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 577
Targeting drugs to tumours using cell membrane-coated nanoparticles
Ronnie H. Fang, Weiwei Gao, Liangfang Zhang
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 33-48
Closed Access | Times Cited: 459
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 403
Lipids and Lipid Derivatives for RNA Delivery
Yuebao Zhang, Changzhen Sun, Chang Wang, et al.
Chemical Reviews (2021) Vol. 121, Iss. 20, pp. 12181-12277
Open Access | Times Cited: 388
The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Alessandra Spada, Jaber Emami, Jack A. Tuszyński, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 5, pp. 1862-1894
Closed Access | Times Cited: 377
Nanodelivery of nucleic acids
Bárbara B. Mendes, João Conniot, Aviram Avital, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 367
Smart nanoparticles for cancer therapy
Leming Sun, Hongmei Liu, Yanqi Ye, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 343
Design of therapeutic biomaterials to control inflammation
Zhaoxu Tu, Yiling Zhong, Hanze Hu, et al.
Nature Reviews Materials (2022) Vol. 7, Iss. 7, pp. 557-574
Open Access | Times Cited: 315
The landscape of mRNA nanomedicine
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 309
Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review
Reza Abbasi, Ghazal Shineh, Mohammadmahdi Mobaraki, et al.
Journal of Nanoparticle Research (2023) Vol. 25, Iss. 3
Open Access | Times Cited: 309
Drug release study of the chitosan-based nanoparticles
Yedi Herdiana, Nasrul Wathoni, Shaharum Shamsuddin, et al.
Heliyon (2021) Vol. 8, Iss. 1, pp. e08674-e08674
Open Access | Times Cited: 306
Lipid Nanoparticles for Drug Delivery
Letao Xu, Xing Wang, Yun Liu, et al.
Advanced NanoBiomed Research (2021) Vol. 2, Iss. 2
Open Access | Times Cited: 297
CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 296
Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status
Gürcan Günaydın, Mustafa Emre Gedik, Seylan Ayan
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 293
Therapeutic in vivo delivery of gene editing agents
Aditya Raguram, Samagya Banskota, David R. Liu
Cell (2022) Vol. 185, Iss. 15, pp. 2806-2827
Open Access | Times Cited: 285
Antioxidants: Classification, Natural Sources, Activity/Capacity Measurements, and Usefulness for the Synthesis of Nanoparticles
Jolanta Flieger, Wojciech Flieger, Jacek Baj, et al.
Materials (2021) Vol. 14, Iss. 15, pp. 4135-4135
Open Access | Times Cited: 282
Nanomedicine in cancer therapy
Dahua Fan, Yongkai Cao, Meiqun Cao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 273
Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?
María Vallet‐Regí, Ferdi Schüth, Daniel Lozano, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 13, pp. 5365-5451
Open Access | Times Cited: 272
Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
Ghazala Muteeb, Md Tabish Rehman, Moyad Shahwan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1615-1615
Open Access | Times Cited: 264
Cancer nanomedicine
Sangeeta N. Bhatia, Xiaoyuan Chen, Marina A. Dobrovolskaia, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 550-556
Open Access | Times Cited: 259
Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
Ashagrachew Tewabe, Atlaw Abate, Manaye Tamrie Derseh, et al.
Journal of Multidisciplinary Healthcare (2021) Vol. Volume 14, pp. 1711-1724
Open Access | Times Cited: 249
Nanoparticles: Taking a Unique Position in Medicine
Tomy Muringayil Joseph, Debarshi Kar Mahapatra, Amin Esmaeili, et al.
Nanomaterials (2023) Vol. 13, Iss. 3, pp. 574-574
Open Access | Times Cited: 249
Microfluidic formulation of nanoparticles for biomedical applications
Sarah J. Shepherd, David Issadore, Michael J. Mitchell
Biomaterials (2021) Vol. 274, pp. 120826-120826
Open Access | Times Cited: 244
Nanoparticles in the clinic: An update post COVID‐19 vaccines
Aaron C. Anselmo, Samir Mitragotri
Bioengineering & Translational Medicine (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 236
Page 1 - Next Page

Scroll to top